Invitation: Take Our Online Survey to Help Improve HIV and PrEP Services in Thailand
Love Foundation and IHRI invite adults in Thailand who self-identify as HIV-negative and meet the study criteria to take a 15–25 minute online survey to help…
อ่านภาษาไทย
Contents
Love Foundation, in partnership with the Institute of HIV Research and Innovation (IHRI), invites Thai people at risk of HIV infection to take part in an online survey. This survey is part of a research project focused on developing long-acting PrEP service models that fit the real-life behaviors, needs, and lifestyles of the people who use them. Your participation will provide important data to help strengthen Thailand's HIV prevention services. Participants who complete the survey will receive 150 baht as a thank-you for their time and valuable input.
What is PrEP, and why does it matter?
PrEP (Pre-Exposure Prophylaxis) is medication taken before potential exposure to HIV to reduce the risk of infection. A newer long-acting form of PrEP (long-acting PrEP) does not require taking a pill every day, which is expected to make HIV prevention more accessible and effective. This research examines how cost-effective long-acting PrEP is and what impact it could have on the HIV epidemic among Thailand's key populations, in order to inform public health policy decisions.
What is this research project?
This survey is part of the research project "A Study of the Epidemiological Impact and Cost-Effectiveness of Long-Acting PrEP Among Key Populations in Thailand," which has been approved by the Research Ethics Committee of the Faculty of Medicine, Chulalongkorn University (IRB No. 0785/65). The project's main goal is to gather data from key populations to help develop national standards for HIV and PrEP services, working toward ending the HIV epidemic in communities and across Thailand.
The benefits of taking part
Your participation is more than just answering a survey—it helps drive meaningful change in the country's health system. The information you provide reflects the voices and needs of real users, which is invaluable for designing services that are easy to access, welcoming, and suited to everyday life. In addition, the research findings can help advance national HIV and PrEP policies and service standards, so that everyone can access effective prevention equally, reducing health disparities and improving quality of life over the long term.
Participant eligibility
✅ Inclusion criteria (all must apply)
- Thai national, able to read, speak, and write Thai
- At least 18 years of age
- Self-identify as HIV-negative
- At risk of HIV infection
❌ Exclusion criteria
- Previously took part in the qualitative data-collection phase of this research project
- Previously took part in the survey pilot testing for this research project
- Not a Thai national and without permanent residence in Thailand
- Staying temporarily or visiting as a tourist
- A participant in the Len4PrEP clinical trial
Survey details
| 📋 Time to complete | About 15–25 minutes |
| 📅 Open | From today until June 30, 2026 |
| 👥 Target number | At least 300 people |
| 💰 Compensation | 150 baht per response |
| 🔒 Confidentiality | Confidential; can be completed only once |
How to take the survey
This survey is now closed. Scan the QR code on the poster or contact Love Foundation to receive the survey link directly. The survey is 100% online—no travel required, and no identification needed.
This survey is part of the research project "A Study of the Epidemiological Impact and Cost-Effectiveness of Long-Acting PrEP Among Key Populations in Thailand," approved by the Research Ethics Committee of the Faculty of Medicine, Chulalongkorn University. IRB No. 0785/65 | Project No. 0785/65 | Approval date: February 10, 2026
Verified references
Links and relevance to the article’s main topic were reviewed on 13 August 2026. Each source supports only the scope stated in the original document and does not replace personalised medical, legal, or service advice.
- กรมควบคุมโรค: แนวทางตรวจ HIV/ซิฟิลิส/HBV/HCV พ.ศ. 2568 Accessed 13 August 2026
- CDC: Clinical Guidance for PrEP Accessed 13 August 2026
- WHO: HIV and AIDS fact sheet Accessed 13 August 2026


